The largest database of trusted experimental protocols

Aria 15

Manufactured by Agilent Technologies
Sourced in United States

The ARIA 15.6 is a laboratory equipment product by Agilent Technologies. It is a compact and portable device designed for general laboratory use. The ARIA 15.6 provides core functionalities for laboratory operations without further interpretation on its intended application.

Automatically generated - may contain errors

2 protocols using aria 15

1

Hybrid IMRT Breast Cancer Radiotherapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients were planned using External Beam Application in ARIA 15.6 (Varian Medical Systems, Palo Alto, California, USA) using a hybrid IMRT technique.23 This technique involves treating the patient with open tangential fields followed by IMRT tangential fields. The open fields are those static fields delivered without MLCs, defined by setting the jaws according to anatomical landmarks of clinical interest. Additional MLC shielding can be added to the open fields to shield the heart or to shield part of the lung when the collimator is set to zero degrees (for patients receiving supraclavicular irradiation). The jaws of the IMRT fields are set to the same size as the static fields, and the plan is optimized to deliver a uniform dose throughout the breast, typically resulting in a smooth sweep of MLCs. The static fields delivered between 50% and 80% of the dose, and these are the fields where EPID images were acquired and the position of the chest wall was identified. This was only done for the static fields since the sweeping MLCs of the IMRT fields will eventually block the chest wall.
+ Open protocol
+ Expand
2

VMAT Radiotherapy for Head and Neck Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients were treated on a Varian TrueBeam™ accelerator using 6 MV photon beams. The treatment plans were generated using the Acuros dose calculation algorithm [31] (link), [32] (link) in ARIA 15.6 (Varian Medical Systems, Palo Alto, CA, USA). The treatment plans consisted of 2 or 4 VMAT (RapidArc) beams (see Table 1). The dose to the PTV was: D98% > 95 % of prescribed dose. The dose to the parotid glands, submandibular glands, oral cavity and swallow structures was minimised as much as possible. The CTV-PTV margin was 3 mm based on in-house analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!